Navigation Links
Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company
Date:7/21/2008

es, she was the lead inventor of crystallographic fragment-based screening, co-inventor of the ACTOR robotic system for automated crystal sample handling and a leader in structure-based drug design methods.

Zenobia's 505 Coast Blvd facility is fully equipped for cloning, expression, purification and crystallization of proteins. Contracts are in place with synchrotron facilities for high-throughput data collection and Zenobia's compound library is available for screening. Drug discovery chemistry and pharmacology will be accessed through contract research organizations and consultants.

For additional information on Zenobia Therapeutics, Inc., contact Dr. Vicki Nienaber at vicki@zenobiatherapeutics.com or visit http://www.zenobiatherapeutics.com.


'/>"/>
SOURCE Zenobia Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Shareholders Approve All Matters Proposed by Cell Therapeutics, Inc. at Special Meeting in Lieu of Annual Meeting of Shareholders
2. Cell Therapeutics, Inc. Repays $11.0 million Balance of 2008 Convertible Debt
3. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Thursday, June 19, 2008
4. Cell Therapeutics, Inc. Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor
5. Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program
6. Cell Therapeutics, Inc. (CTI) to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
7. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
8. Cell Therapeutics, Inc. (CTI) to Report 2008 First Quarter and Financial Results on May 8
9. Cell Therapeutics, Inc. Sells $64.5 million Units Consisting of Preferred Stock, New 2014 Convertible Senior Notes and Warrants to a Single Institutional Investor
10. CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
11. CardioVascular BioTherapeutics, Inc. Announces Update on Timing of Form 10-K Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" ... month periods ended June 30, 2014.  Biorem,s complete 2014 second quarter financial ... Financial Summary:Three-months ended June 30, , Six-months ended ... 2014 , 2013 , 2014 , ... 4,433 , 9,195 Gross profit , 56 ...
(Date:8/22/2014)... 22nd), in the scientific journal PLoS One ... the effect of serotonin on sensitivity to pain ... techniques., "Serotonin is a small molecule known to ... functions, from the control of sleep and appetite, ... neurotransmitter is also popularly thought to contribute to ...
(Date:8/22/2014)... particles are intensively investigated for application as ... agents and components in photonics and molecular ... fundamental for understanding physical and chemical properties, ... University, USA, have demonstrated that high-resolution electron ... three-dimensional structure in which all gold atoms ...
(Date:8/22/2014)... The Global and China Diabetes Drugs Industry is ... of the Diabetes Drug industry in Global and China. ... industry, including definitions, applications and industry chain structure. Global ... with a focus on history, developments, trends and competitive ... and Chinese situation is also offered. , The report ...
Breaking Biology Technology:Biorem Reports 2014 Second Quarter Results 2Biorem Reports 2014 Second Quarter Results 3From happiness to pain: Understanding serotonin's function 2A breakthrough in imaging gold nanoparticles to atomic resolution by electron microscopy 2Diabetes Drugs Industry Growth Analysis in Global, China Regions Research Report Available at DeepResearchReports.com 2Diabetes Drugs Industry Growth Analysis in Global, China Regions Research Report Available at DeepResearchReports.com 3
... having the next big thing is not enough. , ... mid-sized firm occupying several hard-won niches, or a high-energy ... says Tom Miller, an intellectual property lawyer with Michael ... presentation to eInnovate, a Milwaukee-based technology forum, Miller said ...
... , a niche hardware company that makes networking products for ... Chippewa Valley Angel Investors Network . , ,"This [investment] is ... getting our products to market sooner," said Corky Seeber, president ... space and equipment, and to develop additional products." , ,"Were ...
... thousands of manufacturing jobs that have vanished all through ... industries is a fool's errand. Instead, efforts are underway ... the technological inventions coming out of Wisconsin's institutes of ... entities have sprung up with the intent of assisting ...
Cached Biology Technology:Protect your intellectual property before it's too late 2Protect your intellectual property before it's too late 3Chippewa Valley angels invest in network hardware company 2Chippewa Valley angels invest in network hardware company 3Will tech transfer save Wisconsin's economy? 2Will tech transfer save Wisconsin's economy? 3Will tech transfer save Wisconsin's economy? 4Will tech transfer save Wisconsin's economy? 5Will tech transfer save Wisconsin's economy? 6Will tech transfer save Wisconsin's economy? 7Will tech transfer save Wisconsin's economy? 8
(Date:8/22/2014)... discoveries in basic and clinical research and technological ... a complex offensive spanning multiple fronts. , Work ... could help find new and more selective therapies ... targets a specific enzyme overexpressed in certain cancersand ... brain tumours. , Chemistry professor Christopher Cairo and ...
(Date:8/22/2014)... The first comprehensive study of captive black rhino ... improve the success of breeding programmes. , Researchers ... the University of Liverpool carried out a six-year ... black rhino. , Dr Katie Edwards led the ... University of Liverpool. She says: "Although some black ...
(Date:8/22/2014)... 3β-Hydroxysteroid-Δ24 reductase (DHCR24) is a multifunctional ... reticulum and has neuroprotective and cholesterol-synthesizing ... apoptosis caused by amyloid β deposition. ... Liaoning University in China constructed two ... drive DHCR24 expression specifically in neuronal ...
Breaking Biology News(10 mins):New enzyme targets for selective cancer therapies 2New enzyme targets for selective cancer therapies 3Hormone analysis helps identify horny rhinos 2
... assumed we can,t just sniff out danger. It was ... leaking gas only after information about a scary scent is ... studying the olfactory sense of smell system in mice ... level, even before the brain has the opportunity to interpret that ...
... in deep, dark Mexican caves, scientists have found evidence for ... natural selection of spontaneously arising mutations, as reported this week ... eyeless cavefish Astyanas mexicanus is "a special system ... article co-author William Jeffery, a senior adjunct scientist at the ...
... an organ, or to swap it out for an ... to fact. Tissue engineering techniques are improving in their ... them with vascular systems for keeping them alive, but ... is still needed. Researchers at the University of ...
Cached Biology News:Sniffing out danger: Rutgers scientists say fearful memories can trigger heightened sense of smell 2Blind cavefish offer evidence for alternative mechanism of evolutionary change 2Researchers at Penn help develop a dynamic model of tissue failure 2Researchers at Penn help develop a dynamic model of tissue failure 3Researchers at Penn help develop a dynamic model of tissue failure 4
... Using multicolor analysis in a modern flow ... cells that are differentially labeled with fluorescent ... dyes typically used for cell labeling are ... by a flow cytometers filters. Thus, the ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: rack ...
... leading provider of X-ray crystallography services ... screening services to its pharmaceutical and ... binding of drug-like fragments to the ... targets, allowing scientists to develop novel, ...
...
Biology Products: